AG
AVXL icon

Advisor Group’s Anavex Life Sciences AVXL Stock Holding History

Advisor Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$7K Hold
2,700
– – ﹤0.01% 4498
2019
Q3 		$8K Buy
2,700
+200
+8% +$577 ﹤0.01% 4443
2019
Q2 		$9K Sell
2,500
-2,500
-50% -$7.76K ﹤0.01% 4414
2019
Q1 		$15K Buy
5,000
+3,000
+150% +$7.17K ﹤0.01% 4125
2018
Q4 		$3K Buy
+2,000
New +$4.54K ﹤0.01% 4690

Other funds holding AVXL

PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Advisor Group's AVXL Position: Q4 2019 in Review

Advisor Group held its Anavex Life Sciences (AVXL) position steady in Q4 2019 at 2,700 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #4498.

Advisor Group first reported a position in AVXL in Q4 2018 and has held it in 5 quarters since. The position peaked at $15K in Q1 2019. 67 funds tracked by Wall St. Rank hold AVXL as of Q4 2019.

  • Advisor Group held 2,700 shares of Anavex Life Sciences worth $7K as of Q4 2019.
  • Advisor Group left its Anavex Life Sciences share count unchanged in Q4 2019.
  • Anavex Life Sciences made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4498 holding.
  • Advisor Group first reported a position in Anavex Life Sciences in Q4 2018 and has held it in 5 quarters since.
  • Advisor Group's Anavex Life Sciences position peaked at $15K in Q1 2019.
  • 67 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.